Literature DB >> 30382181

Drug addiction: a curable mental disorder?

Jian-Feng Liu1, Jun-Xu Li2.   

Abstract

Drug addiction is a chronic, relapsing brain disorder. Multiple neural networks in the brain including the reward system (e.g., the mesocorticolimbic system), the anti-reward/stress system (e.g., the extended amygdala), and the central immune system, are involved in the development of drug addiction and relapse after withdrawal from drugs of abuse. Preclinical and clinical studies have demonstrated that it is promising to control drug addiction by pharmacologically targeting the addiction-related systems in the brain. Here we review the pharmacological targets within the dopamine system, glutamate system, trace amine system, anti-reward system, and central immune system, which are of clinical interests. Furthermore, we discuss other potential therapies, e.g., brain stimulation, behavioral treatments, and therapeutic gene modulation, which could be effective to treat drug addiction. We conclude that, although drug addiction is a complex disorder that involves complicated neural mechanisms and psychological processes, this mental disorder is treatable and may be curable by therapies such as gene modulation in the future.

Entities:  

Keywords:  behavioral treatment; brain stimulation; drug addiction; gene therapy; pharmacological targets

Mesh:

Substances:

Year:  2018        PMID: 30382181      PMCID: PMC6289334          DOI: 10.1038/s41401-018-0180-x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  108 in total

1.  Blockade of mGluR5 in the nucleus accumbens shell but not core attenuates heroin seeking behavior in rats.

Authors:  Zhong-ze Lou; Ling-hong Chen; Hui-feng Liu; Lie-min Ruan; Wen-hua Zhou
Journal:  Acta Pharmacol Sin       Date:  2014-11-17       Impact factor: 6.150

Review 2.  On the Eve of Upgrading Antidepressants: (R)-Ketamine and Its Metabolites.

Authors:  Kai Yuan; Ying Han; Kenji Hashimoto; Lin Lu
Journal:  Neurosci Bull       Date:  2016-11-14       Impact factor: 5.203

Review 3.  MicroRNAs regulate synaptic plasticity underlying drug addiction.

Authors:  A C W Smith; P J Kenny
Journal:  Genes Brain Behav       Date:  2017-10-10       Impact factor: 3.449

Review 4.  Gene therapy comes of age.

Authors:  Cynthia E Dunbar; Katherine A High; J Keith Joung; Donald B Kohn; Keiya Ozawa; Michel Sadelain
Journal:  Science       Date:  2018-01-12       Impact factor: 47.728

Review 5.  Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders.

Authors:  Douglas J Roberts-Wolfe; Peter W Kalivas
Journal:  CNS Neurol Disord Drug Targets       Date:  2015       Impact factor: 4.388

6.  N-acetylcysteine amide (AD4) reduces cocaine-induced reinstatement.

Authors:  Joanna Jastrzębska; Malgorzata Frankowska; Malgorzata Filip; Daphne Atlas
Journal:  Psychopharmacology (Berl)       Date:  2016-07-28       Impact factor: 4.530

7.  Dose, Plasma Level, and Treatment Outcome Among Methadone Patients in Shanghai, China.

Authors:  Haifeng Jiang; Maureen Hillhouse; Jiang Du; Shujun Pan; Ang Alfonso; Jun Wang; Zhirong Zhou; Weijun Yuan; Walter Ling; Min Zhao
Journal:  Neurosci Bull       Date:  2016-09-10       Impact factor: 5.203

Review 8.  Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits.

Authors:  Gordon F Rushworth; Ian L Megson
Journal:  Pharmacol Ther       Date:  2013-09-28       Impact factor: 12.310

Review 9.  Neuroepigenetics and addiction.

Authors:  Deena M Walker; Eric J Nestler
Journal:  Handb Clin Neurol       Date:  2018

10.  Addiction is a Reward Deficit and Stress Surfeit Disorder.

Authors:  George F Koob
Journal:  Front Psychiatry       Date:  2013-08-01       Impact factor: 4.157

View more
  6 in total

1.  Plants with Anti-Addictive Potential.

Authors:  Eduardo Luis Konrath; Marcelo Dutra Arbo; Bruno Dutra Arbo; Mariana Appel Hort; Elaine Elisabetsky; Mirna Bainy Leal
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Mass spectrometry-based metabolomics in hair from current and former patients with methamphetamine use disorder.

Authors:  Min Jae Seo; Sang-Hoon Song; Suji Kim; Won Jun Jang; Chul-Ho Jeong; Sooyeun Lee
Journal:  Arch Pharm Res       Date:  2021-11-06       Impact factor: 4.946

3.  A double-blind sham-controlled phase 1 clinical trial of tDCS of the dorsolateral prefrontal cortex in cocaine inpatients: Craving, sleepiness, and contemplation to change.

Authors:  Pierre-Olivier Gaudreault; Akarsh Sharma; Abhishek Datta; Ester M Nakamura-Palacios; Sarah King; Pias Malaker; Ariella Wagner; Devarshi Vasa; Muhammad A Parvaz; Lucas C Parra; Nelly Alia-Klein; Rita Z Goldstein
Journal:  Eur J Neurosci       Date:  2021-03-18       Impact factor: 3.386

4.  Predictors of length of abstinence among drug abuse patients of a behavioral modification program in specialized center in Saudi Arabia.

Authors:  Mahmoud Abdulrahman Mahmoud
Journal:  J Family Med Prim Care       Date:  2020-02-28

5.  Exercise Regulates the Metabolic Homeostasis of Methamphetamine Dependence.

Authors:  Xue Li; Kefeng Li; Zhicheng Zhu; Yu Jin; Zhanle Gao; Jisheng Xu; Li Zhang
Journal:  Metabolites       Date:  2022-06-29

6.  Effects of traditional Chinese exercises on mental health in individuals with drug rehabilitee: A systematic review and meta-analysis.

Authors:  Yulong Zhang; Shenghua Lu
Journal:  Front Public Health       Date:  2022-08-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.